These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 1465880

  • 21. Area under the curve of cyclosporine pharmacokinetics: comparison of the characteristics of the pure drug and metabolites.
    Foradori AC, Martínez L, Vacarezza A, Elberg A, Mella G, Loveluck A, Pinto C.
    Transplant Proc; 1992 Dec; 24(6):2614-5. PubMed ID: 1465884
    [No Abstract] [Full Text] [Related]

  • 22. Late graft loss in cadaveric renal transplantation.
    Bergmann L, Roper L, Bow LM, Hull D, Bartus SA, Schweizer RT.
    Transplant Proc; 1992 Dec; 24(6):2718-9. PubMed ID: 1465913
    [No Abstract] [Full Text] [Related]

  • 23. Measures to improve early results in kidney transplantation.
    Schweizer RT, Roper L, Hull D, Bartus S.
    Transplant Proc; 1992 Dec; 24(6):2729-30. PubMed ID: 1465919
    [No Abstract] [Full Text] [Related]

  • 24. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
    Thorogood J, Schreuder GM, Persijn GG, van Rood JJ.
    Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839
    [No Abstract] [Full Text] [Related]

  • 25. Immunosuppression in live-related donor renal transplantation.
    Iman A, Rao M, Juneja R, Jacob CK.
    Natl Med J India; 2001 Dec; 14(2):75-80. PubMed ID: 11396322
    [Abstract] [Full Text] [Related]

  • 26. Effect of donor-specific blood transfusions on graft outcome in live donor renal transplantations.
    Velidedeoğlu E, Tokyay R, Haberal M.
    Transplant Proc; 1992 Dec; 24(6):2752-3. PubMed ID: 1465927
    [No Abstract] [Full Text] [Related]

  • 27. Chronic rejection of renal allografts with four immunosuppressive regimens.
    Isoniemi H, Ahonen J, Krogerus L, Eklund B, Höckerstedt K, Salmela K, Häyry P.
    Transplant Proc; 1992 Dec; 24(6):2716-7. PubMed ID: 1465912
    [No Abstract] [Full Text] [Related]

  • 28. HLA-A, B, DR antigens and renal transplantation from cadaveric donors and living-related donors in Greek patients.
    Adam K, Polymenidis Z, Papakyriazi L, Alexopoulos E, Parapanissiou E, Antoniadis A, Papadimitriou M.
    Transplant Proc; 1992 Dec; 24(6):2449-50. PubMed ID: 1465825
    [No Abstract] [Full Text] [Related]

  • 29. Autoreactive IgM non-HLA antibodies are not entirely clinically irrelevant. The Manchester UK Kidney Transplant Team.
    Martin S, Dyer PA, Scott PD.
    Transplant Proc; 1992 Dec; 24(6):2504. PubMed ID: 1465846
    [No Abstract] [Full Text] [Related]

  • 30. Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies.
    Mjörnstedt L, Konar J, Skarp I, Olausson M, Sandberg L, Tufvesson G.
    Transplant Proc; 1992 Dec; 24(6):2469. PubMed ID: 1465834
    [No Abstract] [Full Text] [Related]

  • 31. Negative crossmatch on current sera and good HLA matching are the main requirements for renal transplantation in highly sensitized patients.
    Cristol JP, Mourad G, Argiles A, Seignalet J, Iborra F, Ramounau-Pigot A, Chong G, Mion C.
    Transplant Proc; 1992 Dec; 24(6):2470-1. PubMed ID: 1465835
    [No Abstract] [Full Text] [Related]

  • 32. Beneficial effect of DR matching on cadaveric renal graft survival in Scandiatransplant.
    Leivestad T, Berger L, Thorsby E.
    Transplant Proc; 1992 Dec; 24(6):2447-8. PubMed ID: 1465824
    [No Abstract] [Full Text] [Related]

  • 33. Postoperative endogenous serum cortisol level as indicator of the immunosuppressive efficacy of prednisolone in kidney allograft recipients.
    Kaden J, Egerer K, May G, Schreiner S, Wesslau C, Schönemann C, Egerer B.
    Transplant Proc; 1992 Dec; 24(6):2622-3. PubMed ID: 1465888
    [No Abstract] [Full Text] [Related]

  • 34. Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era?
    Brayman KL, Egidi MF, Naji A, Friedman AL, Holland MT, Tomaszewski JE, Samini F, Perloff J, Grossman R, Barker CF.
    Transplant Proc; 1994 Oct; 26(5):2525-7. PubMed ID: 7940776
    [No Abstract] [Full Text] [Related]

  • 35. Elective vs systematic corticosteroid withdrawal in renal transplant recipients receiving triple drug therapy.
    Hiesse C, Rousseau P, Kriaa F, Larue JR, Charpentier B.
    Transplant Proc; 1995 Feb; 27(1):1066-7. PubMed ID: 7878807
    [No Abstract] [Full Text] [Related]

  • 36. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
    Posner MP, Mendez-Picon G, King A, Nelson KP, Spicer HG, Lee HM.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
    [No Abstract] [Full Text] [Related]

  • 37. Cold ischemia time and MHC class II matching in renal transplants.
    Iwaki Y, Cicciarelli J, Aswad S, Gavazov M, Obispo E, Khetan U, Bogaard T, Asai P, Mendez RG, Mendez R.
    Transplant Proc; 1992 Dec; 24(6):2456-7. PubMed ID: 1465829
    [No Abstract] [Full Text] [Related]

  • 38. Very low frequency of rejection due to HLA-(A+)B+DQ matching.
    Christiaans MH, van den Berg-Loonen PM, Nieman FH, van Hooff JP.
    Transplant Proc; 1992 Dec; 24(6):2441-2. PubMed ID: 1465822
    [No Abstract] [Full Text] [Related]

  • 39. Determinants of long-term allograft function following steroid withdrawal in renal transplant recipients.
    Hricik DE, Seliga RM, Fleming-Brooks S, Bartucci MR, Schulak JA.
    Clin Transplant; 1995 Oct; 9(5):419-23. PubMed ID: 8541637
    [Abstract] [Full Text] [Related]

  • 40. Value of monoclonal antibody OKT3 in solid organ transplantation: a meta-analysis.
    Carrier M, Jenicek M, Pelletier LC.
    Transplant Proc; 1992 Dec; 24(6):2586-91. PubMed ID: 1465874
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.